- 6-Paradol
-
-
2026-06-04
- CAS:27113-22-0
- Min. Order: 1kg
- Purity: 50%
- Supply Ability: 388kgs
|
| | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one Basic information |
| Product Name: | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one | | Synonyms: | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one;1-(3-Methoxy-4-hydroxyphenyl)-3-decanone;1-(4-Hydroxy-3-methoxyphenyl)decan-3-one;Brn 1984119;Ccris 8519;Einecs 248-228-1;Heptyl 4-hydroxy-3-methoxyphenethyl ketone;Paradol, 6-Paradol | | CAS: | 27113-22-0 | | MF: | C17H26O3 | | MW: | 278.39 | | EINECS: | 248-228-1 | | Product Categories: | | | Mol File: | 27113-22-0.mol |  |
| | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one Chemical Properties |
| Boiling point | 406.4±30.0 °C(Predicted) | | density | 1.0690 g/cm3 | | refractive index | 1.5232 (589.3 nm 20℃) | | FEMA | 4665 | 1-(4-HYDROXY-3-METHOXYPHENYL)DECAN-3-ONE | | storage temp. | Sealed in dry,Room Temperature | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | pka | 10.02±0.20(Predicted) | | color | White to Brown | | Odor | spicy herbal | | Odor Type | spicy | | JECFA Number | 2021 | | Major Application | food and beverages
pharmaceutical | | Cosmetics Ingredients Functions | SKIN CONDITIONING | | InChI | InChI=1S/C17H26O3/c1-3-4-5-6-7-8-15(18)11-9-14-10-12-16(19)17(13-14)20-2/h10,12-13,19H,3-9,11H2,1-2H3 | | InChIKey | CZNLTCTYLMYLHL-UHFFFAOYSA-N | | SMILES | C(C1=CC=C(O)C(OC)=C1)CC(=O)CCCCCCC | | LogP | 3.83 |
| WGK Germany | WGK 2 | | Storage Class | 11 - Combustible Solids |
| | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one Usage And Synthesis |
| Chemical Properties | 6-Gingerol (6-gingerol) is a member of the curcumin family and is one of the main active components of ginger. It is a compound with a pungent flavor, and its chemical structure is similar to that of capsaicin, but its spiciness is only one hundredth, or even one thousandth, of that of capsaicin, and it has very little irritation.6-gingerol contains a phenolic group and an alicyclic ring in its structure, which makes it polar and hydrophobic, and thus affects its biological activity and pharmacological effects. | | Uses | Paradol is a Gingerol related compound from ginger with antioxidant activity and cancer preventive properties. | | Definition | ChEBI: [6]-Paradol is a member of phenols, a ketone and a monomethoxybenzene. | | Synthesis | Under nitrogen protection, 16 g of sodium metal, 3.5 g of anhydrous sodium acetate and 110 g of tetrahydrofuran were added to the reaction flask and stirred at room temperature. A solution consisting of 50 g of olefinic intermediate and 200 g of ethanol was slowly added dropwise and the dropwise process was completed in about 2 hours. The reaction was then heated and refluxed, and the progress of the reaction was monitored by thin layer chromatography (unfolding agent ratio petroleum ether: dichloroethane = 3:2). After the complete disappearance of the raw material, the reaction was continued for 3.5 hours. The reaction was stopped, 10 g of activated carbon was added and refluxing was continued for 0.5 hours. The reaction mixture was filtered and concentrated under reduced pressure to remove the solvent. The residue was washed with water, layered and dehydrated to give a light yellow oily product. The purity of the product was 98% and the yield was 94%. | | in vivo | Administration of Paradol (6-paradol) (10 mg/kg) clearly reduces the number of Iba1-positive cells 1 and 3 days after the challenge. Moreover, Paradol dramatically reduces the number of Iba1-postive cells in periischemic regions even after 3 days following M/R challenge[3]. Paradol (6-paradol) exhibits the strongest anti-inflammatory effect of several paradol compounds in lipopolysaccharide-stimulated BV2 microglia derived from a mouse brain, including 2-, 4-, 6-, 8-, and 10-paradol. Furthermore, Paradol shows the strongest pungency of all of the known paradol analogues. Paradol also shows the highest contact time at the antiobesity site of action on the basis of the results shown for the absorption of the metabolites in this study[4]. | | target | Antifection | | IC 50 | COX-2 | | References | [1] Patent: CN106866393, 2017, A. Location in patent: Paragraph 0045; 0046; 0047; 0048
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1972, p. 3001 - 3006 |
| | 1-(4-hydroxy-3-methoxyphenyl)decan-5-one Preparation Products And Raw materials |
|